Midlands Innovation Immunology Network

Midlands Innovation Immunology Network (MIIN)

Midlands Innovation Immunology Network (MIIN) is a joint partnership across the 7 Midlands Innovation Health institutions which aims to:

  1. Encourage research collaboration and stimulating the building of new collaborative research, innovation and training opportunities.
  2. Promote the development of high-quality collaborative proposals from the Midlands Innovation partnership utilising our assets and ensuring the region is attracting the necessary state-of-the-art research facilities and staff to the region.
  3. Ensure that Midlands Immunology Network is perceived as one of the leading groups promoting research, sharing of equipment and training.
  4. Support activities that raise the profile of the Midlands Immunology Network collaboration regionally and nationally.
  5. Enable the Midlands to respond appropriately to government and research funder policy and ambitions.
  6. Build strong relationships with key stakeholders in government, with funding councils and with local and regional stakeholders.
  7. Create the environment for a growth in collaborations between the Midlands Innovation partners.

   Aston University: Dr Ewan Ross
   University of Birmingham: Dr David Bending
   Keele University: Dr Ella Maysami
   University of Leicester: Professor Dave Cousins
   Loughborough University: Professor Lettie Bishop
   University of Nottingham: Professor Lucy Fairclough (CHAIR)
   University of Warwick: Professor Lawrence Young

MIIN is currently running a series of Midlands Showcase events. For more information and to watch previous events click here
Midlands Strengths and Capabilities Catalogue 
Extracellular Vesicles Nottingham, Aston, Birmingham and Loughborough
Dendritic cells – including lectin receptorsNottingham
Macrophages and Innate immunity Nottingham and Keele
B cells and antibodies – including monoclonalNottingham and Birmingham
 T cells – including Inducible TregNottingham, Loughborough, Birmingham and Leicester
Bacterial pathogenesisNottingham and Leicester
 NK/innate lymphoid cellsLoughborough and Leicester
 Mucosal immunityLoughborough
 Interferons and interleukinsNottingham
 Myeloid cells Birmingham
Autoimmune diseases / Immunotherapy Birmingham and Keele
Inflammation, auto inflammatory diseases, allergy and allergic sensitisationNottingham, Birmingham, Loughborough and Keele
COVID-19 biology (and related e.g. MERS-CoV), serology and immunophenotyping Nottingham and Birmingham
COVID-19 treatment and vaccinationsNottingham and Birmingham
Neuroimmunology and NeuroinflammationKeele
Infectious disease (e.g. malaria) Keele
Lung disease, respiratory infections and COPDNottingham, Birmingham and Leicester
Smoking and E-Cigarettes Nottingham
Cancer – including Tumour models, immunotherapy, paediatrics and cancer vaccinesNottingham, Birmingham, Keele and Loughborough
Mouse modelsNottingham
Liver Immunology and GI diseaseBirmingham
Digital pathologyBirmingham and Warwick
Transplant Immunology and Immunoregulation Birmingham
Exercise and physical activityLoughborough
Regenerative responses and biomaterialsAston, Loughborough, Nottingham and Keele
AMR, disinfectants and coatingsBirmingham
Ageing immune systemAston and Birmingham
Next generation reverse vaccinologyKeele and Birmingham
Drug discoveryKeele
Core laboratory techniquesNottingham and Birmingham (link to Flow Cytometry)



Related Content

Other Regional Collaborations and Networks
Other Regional Collaborations and Networks

A unique academic team that truly integrates knowledge, expertise and resources across four leading institutions to deliver greater insight into children with rare and complex syndromes.

Midlands Mass Spectrometry Group (MMSG)
Midlands Mass Spectrometry Group

The MMSG was established by Midlands Innovation, and affiliated Midlands institutions, in order to coordinate knowledge transfer and equipment sharing among universities based within the region.

Medication Optimisation Research Group
Medication Optimisation Research Group

The group aims to translate research into practice. Membership is open to all with an interest in research into Medication Optimisation.